Behnke S - Search Results

1

Does ultrasound disclose a vulnerability factor for Parkinson's disease?

Behnke S, Berg D, Becker G. Behnke S, et al. J Neurol. 2003 Feb;250 Suppl 1:I24-7. doi: 10.1007/s00415-003-1104-0. J Neurol. 2003. PMID: 12761631 Review.

2

Echogenic substantia nigra in patients with orthostatic tremor.

Spiegel J, Behnke S, Fuss G, Becker G, Dillmann U. Spiegel J, et al. Among authors: behnke s. J Neural Transm (Vienna). 2005 Jul;112(7):915-20. doi: 10.1007/s00702-004-0236-6. Epub 2004 Nov 3. J Neural Transm (Vienna). 2005. PMID: 15526141

3

Ceruloplasmin gene variations and substantia nigra hyperechogenicity in Parkinson disease.

Hochstrasser H, Bauer P, Walter U, Behnke S, Spiegel J, Csoti I, Zeiler B, Bornemann A, Pahnke J, Becker G, Riess O, Berg D. Hochstrasser H, et al. Among authors: behnke s. Neurology. 2004 Nov 23;63(10):1912-7. doi: 10.1212/01.wnl.0000144276.29988.c3. Neurology. 2004. PMID: 15557511

4

Differentiation of Parkinson's disease and atypical parkinsonian syndromes by transcranial ultrasound.

Behnke S, Berg D, Naumann M, Becker G. Behnke S, et al. J Neurol Neurosurg Psychiatry. 2005 Mar;76(3):423-5. doi: 10.1136/jnnp.2004.049221. J Neurol Neurosurg Psychiatry. 2005. PMID: 15716540 Free PMC article. Clinical Trial.

5

Screening for mutations of the ferritin light and heavy genes in Parkinson's disease patients with hyperechogenicity of the substantia nigra.

Felletschin B, Bauer P, Walter U, Behnke S, Spiegel J, Csoti I, Sommer U, Zeiler B, Becker G, Riess O, Berg D. Felletschin B, et al. Among authors: behnke s. Neurosci Lett. 2003 Nov 27;352(1):53-6. doi: 10.1016/j.neulet.2003.08.026. Neurosci Lett. 2003. PMID: 14615048

6

Screening for mutations of the IRP2 gene in Parkinson's disease patients with hyperechogenicity of the substantia nigra.

Deplazes J, Schöbel K, Hochstrasser H, Bauer P, Walter U, Behnke S, Spiegel J, Becker G, Riess O, Berg D. Deplazes J, et al. Among authors: behnke s. J Neural Transm (Vienna). 2004 Apr;111(4):515-21. doi: 10.1007/s00702-004-0125-z. J Neural Transm (Vienna). 2004. PMID: 15057521

7

Application of transcranial sonography in extrapyramidal disorders: updated recommendations.

Berg D, Behnke S, Walter U. Berg D, et al. Among authors: behnke s. Ultraschall Med. 2006 Feb;27(1):12-9. doi: 10.1055/s-2005-858962. Ultraschall Med. 2006. PMID: 16470475 Review.

8

Substantia nigra echomorphology in the healthy very old: Correlation with motor slowing.

Behnke S, Double KL, Duma S, Broe GA, Guenther V, Becker G, Halliday GM. Behnke S, et al. Neuroimage. 2007 Feb 1;34(3):1054-9. doi: 10.1016/j.neuroimage.2006.10.010. Epub 2006 Dec 1. Neuroimage. 2007. PMID: 17141529

9

Cross-sectional study discloses a positive family history for Parkinson's disease and male gender as epidemiological risk factors for substantia nigra hyperechogenicity.

Schweitzer KJ, Behnke S, Liepelt I, Wolf B, Grosser C, Godau J, Gaenslen A, Bruessel T, Wendt A, Abel F, Müller A, Gasser T, Berg D. Schweitzer KJ, et al. Among authors: behnke s. J Neural Transm (Vienna). 2007 Sep;114(9):1167-71. doi: 10.1007/s00702-007-0725-5. Epub 2007 Apr 20. J Neural Transm (Vienna). 2007. PMID: 17446999

10

Hyperechogenicity of the substantia nigra in healthy controls is related to MRI changes and to neuronal loss as determined by F-Dopa PET.

Behnke S, Schroeder U, Dillmann U, Buchholz HG, Schreckenberger M, Fuss G, Reith W, Berg D, Krick CM. Behnke S, et al. Neuroimage. 2009 Oct 1;47(4):1237-43. doi: 10.1016/j.neuroimage.2009.05.072. Epub 2009 Jun 1. Neuroimage. 2009. PMID: 19497378

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

136 results

Search Page